FDA hands Scholar Rock a CRL for spinal muscular atrophy drugnews2025-09-23T11:25:22+00:00September 23rd, 2025|Endpoints News|
FDA rejects Rexulti-Zoloft combo for PTSDnews2025-09-22T19:07:14+00:00September 22nd, 2025|Endpoints News|
FDA approves Stealth’s rare disease drug after past rejection, delaynews2025-09-22T15:05:16+00:00September 22nd, 2025|Endpoints News|
Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drugnews2025-09-19T18:24:36+00:00September 19th, 2025|Endpoints News|
CDC vaccine advisors shelve vote on hepatitis B birth dosenews2025-09-19T14:27:00+00:00September 19th, 2025|Endpoints News|
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinencenews2025-09-19T13:50:56+00:00September 19th, 2025|Medical Device News Magazine|
FDA rescinds lab-developed test rule after court ordernews2025-09-18T19:07:44+00:00September 18th, 2025|Endpoints News|
Rare pediatric voucher reauthorization again advances out of House committeenews2025-09-18T17:57:50+00:00September 18th, 2025|Endpoints News|
Replimune’s stock sinks on rocky path forward for cancer treatmentnews2025-09-18T16:54:56+00:00September 18th, 2025|Endpoints News|
ACIP votes to not recommend combined MMRV shot for kids under 4news2025-09-18T13:44:53+00:00September 18th, 2025|Endpoints News|
